Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 1;106(5):e264-e265.
doi: 10.1097/TP.0000000000004100. Epub 2022 Mar 14.

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept

Jonathan Mitchell  1   2 , Jake Kim  1 , Jennifer L Alejo  1 , Teresa P-Y Chiang  1 , Andrew H Karaba  3 , Joel N Blankson  3 , Tihitina Y Aytenfisu  3 , Amy Chang  1 , Aura T Abedon  1 , Robin K Avery  3 , Aaron A Tobian  3 , Allan B Massie  1   4 , Macey L Levan  1 , Daniel S Warren  1 , Jacqueline M Garonzik-Wang  5 , Dorry L Segev  1   4 , William A Werbel  3
Affiliations

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept

Jonathan Mitchell et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

D.L.S. has received consulting and speaking honoraria from Sanofi, Novartis, CLS Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, Thermo Fisher Scientific, Regeneron, and Astra Zeneca. A.H.K. has received consulting fees from Roche. R.K.A. has study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, Regeneron, Takeda/Shire, and Vir/GSK and is an Associate Reviewer for Transplantation. M.L.L. is the Social Media Editor for Transplantation. The other authors declare no conflicts of interest.

References

    1. Werbel WA, Boyarsky BJ, Ou MT, et al. . Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Ann Intern Med. 2021;174:1330–1332. - PMC - PubMed
    1. Karaba AH, Zhu X, Liang T, et al. . A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients. Am J Transplant. [Epub ahead of print. December 24, 2021]. doi:10.1111/ajt.16933 - PMC - PubMed
    1. Ou MT, Boyarsky BJ, Chiang TPY, et al. . Immunogenicity and reactogenicity after SARS-CoV-2 mRNA vaccination in kidney transplant recipients taking belatacept. Transplantation. 2021;105:2119–2123. - PMC - PubMed
    1. Chavarot N, Morel A, Leruez-Ville M, et al. . Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transplant. 2021;21:4043–4051. - PMC - PubMed
    1. Woldemeskel BA, Kwaa AK, Garliss CC, et al. . Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2. J Clin Invest. 2020;130:6631–6638. - PMC - PubMed

Publication types